Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021

SELL
$233.58 - $259.14 $366,253 - $406,331
-1,568 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$221.91 - $258.6 $106,516 - $124,128
480 Added 44.12%
1,568 $390,000
Q4 2020

Feb 11, 2021

BUY
$216.38 - $257.67 $18,392 - $21,901
85 Added 8.47%
1,088 $250,000
Q3 2020

Nov 10, 2020

BUY
$234.65 - $260.95 $235,353 - $261,732
1,003 New
1,003 $255,000
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $319,463 - $392,025
-1,615 Closed
0 $0
Q1 2020

Apr 30, 2020

SELL
$182.24 - $241.7 $109,708 - $145,503
-602 Reduced 27.15%
1,615 $327,000
Q4 2019

Jan 31, 2020

SELL
$189.21 - $243.2 $81,171 - $104,332
-429 Reduced 16.21%
2,217 $534,000
Q2 2019

Aug 07, 2019

BUY
$166.7 - $195.41 $23,338 - $27,357
140 Added 5.59%
2,646 $488,000
Q4 2018

Jan 31, 2019

SELL
$178.4 - $208.25 $146,288 - $170,765
-820 Reduced 24.65%
2,506 $488,000
Q3 2018

Nov 07, 2018

BUY
$185.29 - $208.89 $19,270 - $21,724
104 Added 3.23%
3,326 $689,000
Q2 2018

Aug 10, 2018

BUY
$166.05 - $186.51 $17,933 - $20,143
108 Added 3.47%
3,222 $595,000
Q1 2018

May 09, 2018

BUY
$169.43 - $198.0 $34,733 - $40,590
205 Added 7.05%
3,114 $531,000
Q4 2017

Feb 09, 2018

BUY
$168.79 - $188.59 $491,010 - $548,608
2,909
2,909 $506,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pictet & Cie (Europe) Sa Portfolio

Follow Pictet & Cie (Europe) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.